A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54))

Lisa M Ebert; Y. C. Liu; C. S. Clements; N. C. Robson; H. M. Jackson; J. L. Markby; N. Dimopoulos; B. S. Tan; Immanuel F Luescher; I. D. Davis; J. Rossjohn; Jonathan Cebon; A. W. Purcell; W. Chen

doi:10.1158/0008-5472.CAN-69-10-COR2

A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54))

Lisa M Ebert, Y. C. Liu, C. S. Clements, N. C. Robson, H. M. Jackson, J. L. Markby, N. Dimopoulos, B. S. Tan, Immanuel F Luescher, I. D. Davis, J. Rossjohn, Jonathan Cebon, A. W. Purcell, W. Chen

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	4553
Number of pages	1
Journal	Cancer Research
Volume	69
Issue number	10
DOIs	https://doi.org/10.1158/0008-5472.CAN-69-10-COR2
Publication status	Published - 15 May 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/0008-5472.CAN-69-10-COR2

Cite this

Ebert, L. M., Liu, Y. C., Clements, C. S., Robson, N. C., Jackson, H. M., Markby, J. L., Dimopoulos, N., Tan, B. S., Luescher, I. F., Davis, I. D., Rossjohn, J., Cebon, J., Purcell, A. W., & Chen, W. (2009). A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54)). Cancer Research, 69(10), 4553. https://doi.org/10.1158/0008-5472.CAN-69-10-COR2

@article{e7b9a0adef5c42e19e78068caef45474,

title = "A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54))",

author = "Ebert, {Lisa M} and Liu, {Y. C.} and Clements, {C. S.} and Robson, {N. C.} and Jackson, {H. M.} and Markby, {J. L.} and N. Dimopoulos and Tan, {B. S.} and Luescher, {Immanuel F} and Davis, {I. D.} and J. Rossjohn and Jonathan Cebon and Purcell, {A. W.} and W. Chen",

year = "2009",

month = may,

day = "15",

doi = "10.1158/0008-5472.CAN-69-10-COR2",

language = "English",

volume = "69",

pages = "4553",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research (AACR)",

number = "10",

}

Ebert, LM, Liu, YC, Clements, CS, Robson, NC, Jackson, HM, Markby, JL, Dimopoulos, N, Tan, BS, Luescher, IF, Davis, ID , Rossjohn, J, Cebon, J, Purcell, AW & Chen, W 2009, 'A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54))', Cancer Research, vol. 69, no. 10, pp. 4553. https://doi.org/10.1158/0008-5472.CAN-69-10-COR2

TY - JOUR

T1 - A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen

T2 - Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54))

AU - Ebert, Lisa M

AU - Liu, Y. C.

AU - Clements, C. S.

AU - Robson, N. C.

AU - Jackson, H. M.

AU - Markby, J. L.

AU - Dimopoulos, N.

AU - Tan, B. S.

AU - Luescher, Immanuel F

AU - Davis, I. D.

AU - Rossjohn, J.

AU - Cebon, Jonathan

AU - Purcell, A. W.

AU - Chen, W.

PY - 2009/5/15

Y1 - 2009/5/15

UR - http://www.scopus.com/inward/record.url?scp=66249147592&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-69-10-COR2

DO - 10.1158/0008-5472.CAN-69-10-COR2

M3 - Comment / Debate

AN - SCOPUS:66249147592

SN - 0008-5472

VL - 69

SP - 4553

JO - Cancer Research

JF - Cancer Research

IS - 10

ER -

A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: Implications for cancer vaccine design (Cancer Research (2009) 69, (1046-54))

UN SDGs

Access to Document

Other files and links

Cite this